Annual Drug Patent Expirations for RYZOLT
Ryzolt is a drug marketed by Purdue Pharma and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has fifty-two patent family members in twenty-six countries.
The generic ingredient in RYZOLT is tramadol hydrochloride. Additional details are available on the tramadol hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at